Screening for rheumatic heart disease: current approaches and controversies
Related Experiment Video
Updated: May 16, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Kathryn Roberts1, Samantha Colquhoun, Andrew Steer
1Menzies School of Health Research, Charles Darwin University, Royal Darwin Hospital Campus, Rocklands Drive, Casuarina, Darwin, NT 0810, Australia.
Insights
Screening for rheumatic heart disease (RHD) in children has improved with echocardiography, but challenges remain. Further research is needed to understand subclinical RHD and improve secondary prevention systems.
Area of Science:
- Cardiology
- Public Health
- Pediatrics
Background:
- Rheumatic heart disease (RHD) significantly impacts children in developing nations and indigenous populations.
- Traditional RHD screening relied on cardiac auscultation, which has limitations.
- Portable echocardiography has enhanced RHD screening sensitivity.
Purpose of the Study:
- To evaluate the evolving landscape of RHD screening in children.
- To address concerns regarding echocardiography's specificity and interpretation of minor abnormalities.
- To highlight the need for long-term studies on subclinical RHD and improved secondary prophylaxis systems.
Main Methods:
- Review of historical and current RHD screening practices.
- Analysis of the impact of portable echocardiography on RHD detection.
- Discussion of public health criteria for disease screening.
Main Results:
- Echocardiography offers improved sensitivity for RHD detection compared to auscultation.
- Concerns exist regarding the specificity of echocardiography and the interpretation of subtle findings.
- The natural history of echocardiographically detected subclinical RHD in children is largely unknown.
Conclusions:
- RHD screening using echocardiography presents both advancements and challenges.
- Long-term follow-up studies are crucial to understand the significance of early RHD detection.
- Effective RHD screening requires concurrent improvements in secondary prophylaxis delivery systems.
Abstract:
Rheumatic heart disease (RHD) is a leading cause of cardiac disease among children in developing nations, and in indigenous populations of some industrialized countries. In endemic areas, RHD has long been a target of screening programmes that, historically, have relied on cardiac auscultation. The evolution of portable echocardiographic equipment has changed the face of screening for RHD over the past 5 years, with greatly improved sensitivity. However, concerns have been raised about the specificity of echocardiography, and the interpretation of minor abnormalities poses new challenges. The natural history of RHD in children with subclinical abnormalities detected by echocardiographic screening remains unknown, and long-term follow-up studies are needed to evaluate the significance of detecting these changes at an early stage. For a disease to be deemed suitable for screening from a public health perspective, it needs to fulfil a number of criteria. RHD meets some, but not all, of these criteria. If screening programmes are to identify additional cases of RHD, parallel improvements in the systems that deliver secondary prophylaxis are essential.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease IV: Nursing Management
Mitral Stenosis III: Medical Management
Endocarditis III: Medical Management